OUR STORY

Our journey started back in 2014, from the findings from the deep jungles of Koraput, one of the remotest and poorest districts of Odisha. Opunika® (previously known as Omaria) was discovered to effectively fight malaria. Opunika® is the only natural product for malaria, that has been formulated in India, validated in European labs, and field-tested in Africa. Derived from a wild cultivar of Punica granatum rind, the novel anti-malarial product has therapeutic as well as preventive efficacy against vivax and falciparum malaria. With a mammoth mission to eradicate malaria by 2030, Consytel Life Sciences Private Limited (known as Consytel Life Sciences) was founded in 2017. We have embarked on a mission to annihilate Malaria and Dengue from India and working on innovative approaches Including but not limited to, formulations and smart AI-powered, IoT-enabled devices for vector control. Our portfolio would encompass evidence-backed botanical drugs for disease therapies not adequately addressed through modern medicine. We are striving to enhance wellness and wellbeing – we are changing the way of living.

ABOUT US

Consytel Life Sciences (P) Ltd is an early traction startup in the healthcare space, driven by the aspiration to address therapeutic areas not adequately addressed through modern medicine. Our portfolio would focus on evidence-backed botanical drugs for such unmet clinical needs. One of the R&D priority areas is the annihilation of Vector-borne diseases for which we have been funded through BIRAC (Govt. of India). We are also working on certain biopharmaceuticals in the area of allergy and immunology. Our deep understanding of vector biology and related pharmacology has facilitated an innovative medical device that is AI-driven and IoT enabled to aid smart living which is at an advanced stage of progress. We are also working on functional nutraceuticals to slow down and possibly retard the onset of certain chronic diseases and to promote healthy aging. We are incubated at Atal Incubation Centre at CCMB, Hyderabad, which is a deep life science incubator in India.

MEET OUR PROMOTER

“There is far more opportunity than there is the ability” has been the guiding philosophy of the founder, S.K.Dash. Capitalizing on the experience garnered in Pharmaceuticals, Biotech and Vaccines segments over 28 years and counting, in sales, marketing, and business development has founded Consytel Life Sciences Pvt Ltd. This entrepreneurship has been on a startup mode addressing unmet clinical needs. With a graduate honors degree in Physics and an MBA in marketing, his areas of interest are evidence-backed phytopharmaceuticals, biopharmaceuticals, and IT applications in healthcare.

OUR ENABLING PARTNERS

About Us

Consytel Life Sciences (P) Ltd is a deep life science startup driven by the aspiration to address unmet therapeutic gaps through cogent multimodal solutions. The company has chosen to pursue three distinct verticals-Formulations, Biopharmaceuticals and Medical devices. We are incubated at Atal Incubation Centre (AIC-CCMB), Hyderabad, which is a deep life science incubator in India. We are striving to enhance wellness and wellbeing – we are changing the way of living.